Eric A. Hughes, Executive VP Global R&D and Chief Med Officer: Teva Pharmaceutical Industries TEVA Planned sale · Filed 08/03

Trade details

Type: Planned sale notice
Stock: Teva Pharmaceutical Industries TEVA
Person: Eric A. HughesExecutive VP Global R&D and Chief Med Officer
Planned sale date: 26/08/03
Filed: 26/08/03

$892.1K to be sold

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 07/04~09/02

Eric A. Hughes's recent trades

Eric A. HughesSee "Remarks"
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$301.9K
9,533 sh
$301.9K
Filed 03/09
Traded 03/05
Eric A. HughesSee "Remarks"
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$366.1K
11,277 sh
$366.1K
Filed 03/06
Traded 03/04
Eric A. HughesOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$301.9K
9,533 sh
$301.9K
Filed 03/05
Traded 03/05
Eric A. HughesSee "Remarks"
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$2.2M
68,685 sh
$2.2M
Filed 03/05
Traded 03/03
Eric A. HughesSee "Remarks"
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$390.8K
12,077 sh
$390.8K
Filed 03/05
Traded 03/03